TMC the metals company Inc. (NASDAQ:TMC) Q4 2025 Earnings Call Transcript March 27, 2026 TMC the metals company Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.

Digital Clinical Trial Revenue -- Rose 30% over the previous three-quarter average.

Gross margin compression noted, with gross profit as a percentage of net sales falling to 37.9% for the quarter due to a less ...

Simulations Plus, Inc. (NASDAQ:SLP) Q2 2026 Earnings Call Transcript April 9, 2026 Simulations Plus, Inc. beats earnings expectations. Reported EPS is $0.35, expectations were $0.27. Operator: ...

Good morning, ladies and gentlemen, and welcome to the goeasy Q4 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Thursday, March 26 -- on Wednesday, April 1, 2026 ...

Lantern Pharma Inc. ( LTRN) Shareholder/Analyst Call April 9, 2026 8:30 AM EDT ...

Potential Priority Review Vouchers (PRVs) -- The HLHS program holds rare pediatric disease designation, making Longeveron eligible for a PRV if approved; PDCM program could also achieve PRV ...

Thank you, Steven. In the short time since the early and full approval of Pap smear in August, the standard of care ...

Origin Materials, Inc. (NASDAQ:ORGN) Q4 2025 Earnings Call Transcript March 27, 2026 Origin Materials, Inc. misses on ...

NextNav(NASDAQ:NN) reported substantial strategic progress by accelerating regulatory momentum through the FCC’s NPRM advancement and expanding the company’s market presence internationally via a ...

Bill Larkin stated, "High Pressure Control and Systems revenues for fiscal Q1 2025 (period ended March 31, 2025) was $1.4 ...

INmune Bio, Inc. (NASDAQ:INMB) Q4 2025 Earnings Call Transcript March 30, 2026 INmune Bio, Inc. beats earnings expectations.